Published On: Wed, Oct 19th, 2016

Henry Schein, Inc. (NASDAQ:HSIC) Updated Analyst Coverage


A number of investment brokers have recently updated their price targets on shares of Henry Schein, Inc. (NASDAQ:HSIC).

Most recent broker ratings

10/14/2016 – Henry Schein, Inc. was downgraded to “neutral” by analysts at Robert W. Baird. They now have a USD 164 price target on the stock.

10/11/2016 – Henry Schein, Inc. was upgraded to “buy” by analysts at Goldman Sachs. They now have a USD 185 price target on the stock.

10/06/2016 – UBS began new coverage on Henry Schein, Inc. giving the company a “buy” rating. They now have a USD 186 price target on the stock.

09/12/2016 – Bank of America Merrill Lynch began new coverage on Henry Schein, Inc. giving the company a “buy” rating. They now have a USD 185 price target on the stock.

05/04/2016 – Henry Schein, Inc. had its “outperform” rating reiterated by analysts at Barrington Research. They now have a USD 188 price target on the stock.

03/16/2016 – Credit Suisse began new coverage on Henry Schein, Inc. giving the company a “neutral” rating. They now have a USD 170 price target on the stock.

02/11/2016 – Henry Schein, Inc. had its “neutral” rating reiterated by analysts at Piper Jaffray. They now have a USD 159 price target on the stock.

02/11/2016 – Henry Schein, Inc. had its “market perform” rating reiterated by analysts at Leerink Swann. They now have a USD 170 price target on the stock.

12/03/2015 – Henry Schein, Inc. had its “buy” rating reiterated by analysts at Evercore ISI. They now have a USD 154 price target on the stock.

11/06/2015 – Henry Schein, Inc. was downgraded to “hold” by analysts at Gabelli.

11/05/2015 – Henry Schein, Inc. had its “outperform” rating reiterated by analysts at RBC Capital. They now have a USD 170 price target on the stock.

03/30/2015 – Henry Schein, Inc. had its “hold” rating reiterated by analysts at Zacks.

01/27/2015 – Henry Schein, Inc. had its “hold” rating reiterated by analysts at Stifel Nicolaus.

11/07/2014 – Henry Schein, Inc. had its “neutral” rating reiterated by analysts at JP Morgan. They now have a USD 131 price target on the stock.

03/10/2014 – Henry Schein, Inc. was upgraded to “buy” by analysts at Ned Davis Research.

The share price of Henry Schein, Inc. (NASDAQ:HSIC) was up +0.09% during the last day of trading, with a day high of 154.62. 594601 shares were traded during the last session.

The stock’s 50 day moving average is 161.57 and its 200 day moving average is 169.75. The stock’s market capitalization is 12.54B. Henry Schein, Inc. has a 52-week low of 142.64 and a 52-week high of 183.00.

Henry Schein, Inc. is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments. This segment distributes consumable products, equipment, pharmaceuticals, infection-control products and vitamins. Its global dental group serves office-based dental practitioners, schools and other institutions. The technology and value-added services segment group provides software, technology and other value-added services to health care practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis, e-services, as well as education services for practitioners.